Adaptive Biotechnologies (ADPT) EBITDA Margin (QoQ) (2018 - 2026)
Adaptive Biotechnologies (ADPT) EBITDA Margin (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.40 Bn | 209.33 Bn | 8.34 Bn |
| 2 | Danaher | 139.94 Bn | 135.59 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.03 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.32 Bn | 37.24 Bn | 1.44 Bn |
| 6 | Natera | 38.47 Bn | 37.37 Bn | 696.04 Mn |
| 7 | Illumina | 29.98 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.52 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.21 Bn | 25.58 Bn | 1.03 Bn |
| 10 | Adaptive Biotechnologies | 3.80 Bn | 3.58 Bn | 52.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -136.00 |
| Dec 31, 2025 | 1,107.00 |
| Sep 30, 2025 | 1,772.00 |
| Jun 30, 2025 | 727.00 |
| Mar 31, 2025 | -376.00 |
| Dec 31, 2024 | 1,059.00 |
| Sep 30, 2024 | 173.00 |
| Jun 30, 2024 | 4,116.00 |
| Mar 31, 2024 | -7,364.00 |
| Dec 31, 2023 | 8,501.00 |
| Sep 30, 2023 | 24,365.00 |
| Jun 30, 2023 | -22,378.00 |
| Mar 31, 2023 | -2,755.00 |
| Dec 31, 2022 | 2,399.00 |
| Sep 30, 2022 | 2,527.00 |
| Jun 30, 2022 | 4,305.00 |
| Mar 31, 2022 | -91.00 |
| Dec 31, 2021 | -1,968.00 |
| Sep 30, 2021 | -1,347.00 |
| Jun 30, 2021 | -2,186.00 |